Conference Agenda

19 November

08:00

Registration and Breakfast
09:00

Welcome Address
Josh Dance,
SVP, LSX

KEYNOTE PRESENTATION: STATE OF THE STATE

Gil Bar-Nahum,
Managing Director, Jefferies

09:20

PlenSess-1-1
KEYNOTE PANEL: GLOBAL CAPITAL AND INVESTMENT TRENDS - WHERE NEXT FOR EUROPEAN LIFE SCIENCES?
Executives of leading investment funds discuss major trends impacting the European life sciences sector; rise of the mega-rounds, refocussing of Asian investment interest from US to European into life sciences, US to Europe capital flow, the US/Europe public markets dilemma and supporting the most exciting new technology areas with new funds.

William Hicks, Co-Chair, Securities & Capital Markets Practice, Mintz (moderator)
Maina Bhaman,
Partner, Sofinnova
Vanessa Malier, Managing Partner, Kurma Partners
Roel Bulthuis, Managing Partner, INKEF Capital
Laia Crespo, Head of Europe, Sanofi Ventures
Giovanni Mariggi, Partner, Medicxi
Regina Hodits, Managing Partner, Wellington Partners

10:05

Networking Break

10:30

Oncology & Advanced Therapies


Biotech Therapeutics 1


Biotech Therapeutics 2


Medtech and Healthtech


1-2-1 Partnering

10.30

10.45

11.00

11.15

Storm Therapeutics 300xAimm Therapeutics 300xMy Personal Therapeutics 300xCaladrius Biosciences 300x

Mitotech

Dyadic 300xPrimex PharmaDestiny Pharma

Epiendo 300xHalioDxAllecra Therapeutics 300xEvox therapeutics

metabolomic diagnosticsNovian Health 300xThrive Bioscience-588191-editedAmra Medical

11:30

Oncology & Advanced Therapies


Biotech Therapeutics 1


Biotech Therapeutics 2


Medtech and Healthtech


11.30

11.45

12.00

12.15

12:30

Micregen-1Scancell-1-1-1Immunicum 300px-1East Anglia Therapeutics 300x

Artelo BiosciencesMGB BiopharmaixicoShield Therapeutics

Evonetix 300xUGA Biopharma 300xDicotLightcase New Logo

MiDiagnostics 300x-1Biofidelity 300xCastor 300xSurgify 300x

12:30

Lunch Break

13:30

Oncology & Advanced Therapies


Biotech Therapeutics 1


Biotech Therapeutics 2


Biotech / Medtech


1-2-1 Partnering

13.30

13.45

14.00

14.15

Rakuten Medical 300xMacrophage Pharma 300xValo Tx 300x-1Tilt Biotherapeutics

XBrane_BiopharmaRexgenero_LogoCrystals First 300xBone Therapeutics 300x-1-1

Nerre TherapeuticsKandy TherapeuticsMicrobiotica 300xCleara Biotech 300x

MIP DiagnosticsDelta 4IOP 300x-1Illustratum

14:30

Oncology & Advanced Therapies


Biotech Therapeutics 1

Biotech Therapeutics 2

Biotech / Medtech

14.30

14.45

15.00

15.15

Sprint Bioscience 300xZelluna 300xLocate Bio 300xBio Invent 300x

Brainstorm Cell TherapeuticsBLACKBELT
THERAPEUTICS

CEnsoSolascure 300x

Pharmacytics-1Beoro Tx 300xLempo TX 300xDC4U 300x

ZilicoHemogenyx 300x
Senolytx 300x-1Enzyre 300x

15:30

Afternoon Break

16:00

PlenSess-1-1
CLOSING PANEL: BUILDING EUROPEAN SUCCESS STORIES IN THE US
Building a network, presence and raising capital in the World's largest Pharma market is a no-brainer for life science companies with serious ambitions. Executives of some of Europe's international life science leaders with track records of internationalising their business discuss the keys to successfully raising capital, building partnerships and developing in the US and how to effectively grow on both sides of the Atlantic.

Jonathan Kravetz, Chair, Securities & Capital Markets Practice, Mintz (moderator)
Britt Meelby Jensen,
CEO, Atos Medical
Harpreet Singh,
CEO, Immatics Biotechnologies
Reinhard Kandera,
CFO, HOOKIPA Pharma


16:4517:00

Close of Conference

18:00

Lifestars Fixed-1-1 

Join 500+ life science executives
at the annual awards dinner and ceremony and be part of Europe's biggest celebration of excellence in your industry!

DOWNLOAD BROCHURE